Table 9.
The modified Rankin Scale scores assessed at discharge within 3 months or at 3 months after onset, in patients treated within 24 h after onset.
Grade | 0 | 1 | 2 | 3 | 4 | 5 | Death | |
---|---|---|---|---|---|---|---|---|
Edaravone (n = 42) | 14 | 10 | 8 | 5 | 2 | 2 | 1 | p = 0.0001* |
Placebo (n = 39) | 1 | 6 | 13 | 3 | 8 | 4 | 4 |
Grade: 0, no symptoms at all; 1, no significant disability despite symptoms; 2, slight disability; 3, moderate disability; 4, moderately severe disability; 5, severe disability. *Wilcoxon’s rank sum test.